Co-Authors
This is a "connection" page, showing publications co-authored by Nir Eyal and Tobias Gerhard.
Connection Strength
1.185
-
Do coronavirus vaccine challenge trials have a distinctive generalisability problem? J Med Ethics. 2021 Jun 07.
Score: 0.950
-
Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests. Vaccine. 2021 06 11; 39(26):3455-3458.
Score: 0.236